Inventor · disambiguated record
Gernot Stuhler
Also filed as: STUHLER GERNOT
2 granted patents·7 pending applications·2 citations·filing 2004–2024
38Inventor score
Files withUNIV WUERZBURG J MAXIMILIANS4STUHLER GERNOT2UNIV EBERHARD KARLS2JULUS MAXIMILIANS UNIVERSITÄT WÜRZBURG1
Top patents by PatentIndex Score
9 records- 0175US11427644B2Dual antigen-induced bipartite functional complementationUNIV WUERZBURG J MAXIMILIANS·Filed 2019·Granted Aug 30, 2022·2 cites·16 claims
- 0264US2022340681A1Dual antigen-induced bipartite functional complementationUNIV WUERZBURG J MAXIMILIANS·Filed 2022·Application pending·0 cites
- 0353US2025171525A1Specific dosage regimen for hemibody therapySTUHLER GERNOT·Filed 2024·Application pending·0 cites
- 0452US2024294673A1Recombinant proteinaceous binding moleculesUNIV WUERZBURG J MAXIMILIANS·Filed 2022·Application pending·0 cites
- 0541US2015079093A1Dual antigen-induced bipartite functional complementationJULUS MAXIMILIANS UNIVERSITÄT WÜRZBURG·Filed 2013·Application pending·0 cites
- 0640US7939266B2Treatment of transformed or infected biological cellsUNIV EBERHARD KARLS·Filed 2004·Granted May 10, 2011·0 cites·5 claims
- 0737US2008069772A1Treatment of transformed or infected biological cellsUNIV EBERHARD KARLS·Filed 2007·Application pending·0 cites
- 0834US2021070846A1Specific dosage regimen for hemibody therapySTUHLER GERNOT·Filed 2018·Application pending·0 cites
- 0931US2018208657A1Recombinant antibody molecule and its use for target cell restricted t cell activationUNIV WUERZBURG J MAXIMILIANS·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →